Jonathan Mermin, MD, MPH RADM, USPHS

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

Working world wide against HIV for the health and human rights of men who have sex with men Working world wide against HIV for the health and human rights.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.
HIV and Injection Drug Use
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Safer Needle Devices: Protecting Health Care Workers.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
INJECTION DRUG USE IN METROPOLITAN CINCINNATI Judith Feinberg, MD Professor of Medicine University of Cincinnati College of Medicine November 12, 2012.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
Strategic Plan Challenges and Opportunities David Lakey, MD Commissioner, DSHS.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
STD Control Branch Addressing HCV through a Drug User Health Framework NASTAD Viral Hepatitis Technical Assistance Meeting, October 21, 2014 Washington,
1 HIV and Injection Drug Use HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Introduction to NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director Jonathan Mermin, MD, MPH National.
Pennsylvania: The State of HCV 2015
Injection Drug Use and Hepatitis C What Can We Do About It? Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse.
Hepatitis C: The Silent Epidemic Wednesday, October 21, 2015 John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention.
Hepatitis C: Where are we? Where do we want to go?
H. Dawn Fukuda Director, Office of HIV/AIDS Massachusetts Department of Public Health United States Conference on AIDS Washington, D.C. September 10-13,
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015 Joan M. Duwve, MD, MPH Associate Dean for Public Health.
Lessons from Indiana HIV and Hepatitis C Wisconsin HIV Community Planning Statewide Action Planning Group Meeting Green Lake June 25,
Innovative Strategies for Addressing Hepatitis C in Indian Country March 14, 2016.
HHS Implementation Guidance to Support Certain Components of Syringe Services Programs, 2016: Requesting a Determination of Need in Consultation with CDC.
Diane M. Janowicz, MD Assistant Professor of Clinical Medicine Indiana University School of Medicine Indianapolis, Indiana Persistent Challenges of HIV.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Federal Welcome: A View from the Office of HIV/AIDS and
Name(s) Here Job Title(s) Here.
Quick Review This presentation is the first in a series of presentations intended to familiarize you with disparities calculation Part I: YOU ARE HERE!
Hepatitis C Virus Program in Chicago
State Office of AIDS Update
By: DR.Abeer Omran Consultant pediatric infectious disease
Addressing Viral Hepatitis
Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator
screening, brief intervention and referral to treatment
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Hepatitis C Allies of Philadelphia August 2, 2017
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Health Care for the Homeless and Hepatitis National Hepatitis Coordinators' Conference January 27, 2003 Presented by: Amy M. Taylor, MD, MHS Deputy Chief,
Nhial Tutlam, PhD, MPH 2017 CSTE Annual Conference June 5, 2017
Hepatitis C Incidence and Prevalence in the U.S.
Edo Agustian Indonesian Drug Users Network
Summary Report: Management of Hepatitis C in Prisons
Viral Hepatitis in Correctional Settings
Addiction and the Opioid Crisis: HHS Update
ROOM project Addressing the Opioid Epidemic in the U.P.
Hepatitis C Screening Best Practices Jenitza Serrano-Feliciano M.D
Medication Assisted Treatment
Hidden Casualties: The Opioid Crisis and Infectious Diseases
Needle exchange program
Opioids in Butte County
There are over 200 syringe access service programs (SSP) in the United States. These programs provide sterile syringes to people who inject drugs and.
Hepatitis C Tennessee Caring Ambassadors, Senate Briefing May 18, 2018
The HIV Epidemic among People who Inject Drugs
Pain Management and Substance Use Disorders: JCPP Strategic Session
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
An effectiveness of Hepatitis B intervention to prevent transmission of Hepatitis B virus to the infants. John A, Orisasona, MPP., M.P.H. Walden University.
State Response to Opioids and Infectious Disease
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
STD’S: VIRAL OR BACTERIAL
Town of Collingwood Council September 10th, 2018 Mia Brown RN BScN
Strategic Initiatives to Address Opioid Overdose & Addiction
Human Dignity and Harm Reduction
United States: From outbreak to program response Karen Hoover, MD, MPH Centers for Disease Control and Prevention July 24, 2019 Welcome, and thank you.
Presentation transcript:

The Intersection of Opioids and Viral Hepatitis – A Public Health Crisis Jonathan Mermin, MD, MPH RADM, USPHS Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Caring Ambassadors Program U.S. Senate Briefing May 18, 2018 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Office of the Director

Hepatitis A Outbreaks in Multiple States CDC has been assisting with multiple multi-state hepatitis A outbreaks Primarily among homeless persons, persons who use injection and non-injection drugs, and their close contacts More than 2,100 cases; 49 deaths Over 1,500 hospitalizations Tested more than 1,600 specimens Major challenge for jurisdictions

Acute Hepatitis C Infections Continue to Soar Over 22,000 Americans die of viral hepatitis each year Hepatitis B Hepatitis C Source: National Notifiable Diseases Surveillance System (NNDSS)

Increased Transmission of Viral Hepatitis to Infants Without preventive treatment, 40% of infants born to HBV-infected mothers will develop chronic infection Without treatment, a quarter will die from liver disease From 2009-2014, HCV infection among women giving birth nearly doubled MMWR, May 12, 2017; https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm

Why is viral hepatitis getting worse?

Geographic correlation between opioid prescriptions, drug poisoning deaths, and HCV infections Amounts of opioids prescribed, by county, 2015 Drug poisoning death rates, by county, 2016 Reported New HCV Infections, 2013-14

Other Severe Infectious Consequences to Opioid Use From 2002 to 2012: Hospitalizations due to opioid use and: Endocarditis ↑46% Septic arthritis ↑166% Epidural abscess ↑164% Osteomyelitis ↑115% Other costly health consequences: Neonatal Abstinence Syndrome increased 300% from 1999-2013 Cost >$1.5 billion per year Necrotic skin ulcer Endocarditis

What can we do? Treatment of Substance Use Disorder Prevention of Harmful Opioid Use Prevention of Viral Hepatitis Treatment of Substance Use Disorder Viral Hepatitis Treatment

44 states and Puerto Rico have areas that are experiencing, or at risk for, increases or outbreaks of HCV/HIV Just Released: Managing HIV and hepatitis C outbreaks among persons who inject drugs - A guide for state and local health departments

Comprehensive Community Action Mobilize multi-sector community action, including healthcare, education agencies, public health, and law enforcement Comprehensive community prevention programs Syringe Services Programs (SSPs) prevent overdoses; link patients to treatment; do not increase drug use or crime People who used SSPs 3 times more likely to stop injecting ~50% reduction in incidence of HCV and HIV with a greater effect when combined with substance use treatment Mobilize multi-sector community action, including healthcare, public health, and law enforcement Comprehensive syringe service programs (SSPs) Substance use treatment, naloxone HIV and hepatitis testing and treatment Sterile equipment, vaccination SSPs prevent infections; do not increase drug use or crime 58% reduction in incidence of HIV and 52% in HCV Greater effect combined with substance use treatment In 103 cities worldwide, HIV infection declined 19% in cities with SSPs vs. 8% in others People who used SSP 3.5 times more likely to stop injecting Cost saving MacArthur BMJ 2012. Aspinall E J et al. Int J. Epidemiology, 2014; Turner Addiction 2011; Hagan J Sub Abuse Treatment 2000; Sypsa JID 2017

Improve Disease Prevention Strategies Respond quickly and comprehensively to Hepatitis A clusters Ensure Hepatitis B vaccines and testing are reaching the people who need them Increase screening, diagnosis, and treatment of Hepatitis C and reduce barriers to treatment access Access to HCV treatment among Medicaid enrollees varies by state Source: NVHR, Center for Health Law and Policy Innovation, Harvard University; StateofHepC.org

Think Big, Act Fast The opioid epidemic is increasing infectious diseases Situation is not inevitable Acting quickly and at scale will prevent spread of infectious diseases and reduce overdose deaths Successful action will reduce drug use, save lives, and save money